Evidence map›Paper›PMID 9795762›Full record

ReviewImmunological reviews1998

Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo?

P Borrow, G M Shaw

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Infection of dendritic cells by lymphocytic choriomeningitis virus.Current topics in microbiology and immunology · 2003
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

P BorrowEdward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, UK. seph.borrow@bbsrc.ac.uk
G M Shaw
Jenner Institute · GBUniversity of Alabama at Birmingham · US

Funding

UAB AIEDRP: Immune Control and Escape in Acute InfectionU01AI041530 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KILBY, JOHN MICHAEL · 1997 to 2006
$7.0M
ROLE OF ANTIVIRAL CTLS IN CONTROL OF HIV 1 IN MANR01AI037430 · NIAID · EDWARD JENNER INSTITUTE · PI BORROW, PERSEPHONE · 1997 to 1999
–
ROLE OF ANTIVIRAL CTLS IN CONTROL OF HIV 1 IN MANR29AI037430 · NIAID · SCRIPPS RESEARCH INSTITUTE · PI BORROW, PERSEPHONE · 1995 to 1996
–
NIAID NIH HHS AI37430-03NIAID NIH HHS U01 AI41530
6 · The paper itself

Abstract

Although viral variants which are not recognized by epitope-specific cytotoxic T lymphocytes (CTL) have been shown to arise during a number of persistent virus infections, in many cases their significance remains controversial: it has been argued that the immune response is sufficiently plastic to contain their replication. In this review, we describe the mechanisms by which amino acid changes in viral proteins may affect epitope recognition by virus-specific CTL, and discuss the viral and immunological basis for the emergence of viral variants bearing such amino acid changes during infection. We then consider the impact that viral variation may have on the host CTL response and its ability to contain virus replication. We argue that the emergence of a viral variant demonstrates that it must have an in vivo replicative advantage, and that as such, the variant must tip the balance between virus replication and immune control somewhat in favor of the virus. Further, we suggest that although the immune response can evolve to recognize new viral epitopes, the CTL generated following such evolution frequently have a reduced ability to contain virus replication. We conclude that this escape mechanism likely does make a significant contribution to persistence/pathogenesis during a number of different virus infections.

Indexed as

Antigenic VariationAmino Acid SequenceAntigens, ViralEvolution, MolecularHumansMolecular Sequence DataPeptidesT-Lymphocytes, CytotoxicVirus DiseasesAntigens, ViralPeptides

Identifiers

PMID9795762
PMCPMC7165923
OpenAlexW1990786990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.